Protagenic Therapeutics, Inc.\new (PTIX) › Cash & EquivalentsProtagenic Therapeutics, Inc.\new (PTIX) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2013: $156.0K2014: $22.7K2015: $3.3K2016: $3.10M2017: $399.7K2018: $362.5K2019: $798.6K2020: $671.1K$671.1K2013Cash & Equivalents (USD)2020Fiscal YearCash & EquivalentsChange YoY2020$671.1K-16.0%2019$798.6K+120.3%2018$362.5K-9.3%2017$399.7K-87.1%2016$3.10M+92643.0%2015$3.3K-85.3%2014$22.7K-85.4%2013$156.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share